國家衛生研究院 NHRI:Item 3990099045/15438
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 914242      線上人數 : 1320
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15438


    題名: The cost and effectiveness of different adherence to anti-osteoporosis medication: A population-based cohort study
    作者: Wang, CY;Fu, SH
    貢獻者: National Center for Geriatrics and Welfare Research
    摘要: Objective: To assess the cost and the effectiveness relationship of different adherence to anti-osteoporosis medication (AOM) therapy under the real-world National Health Insurance reimbursement scenario in Taiwan. Methods: The study used Taiwan’s National Health Insurance Research Database to identify patients who initiated AOMs (alendronate and denosumab) between 2008–2017. The study population was categorized into 4 groups according to the different levels of adherence to their AOMs therapy: Medication possession ratio (MPR) C 75%, 50 * ~75%, 25 * ~ 50%, and ~25%. The direct medical cost and the occurrence of subsequent fractures within three years were estimated, and the failure probability of composite osteoporotic fracture was estimated by the Kaplan–Meier method. The concept of the incremental cost-effectiveness ratio was adopted to evaluate the relationship between the cost and effectiveness of AOM treatment at different adherence levels. Results: 166,187 new hip fracture patients who started alendronate between 2008–2017. Among those with higher adherence to AOM had a lower event rate of composite osteoporotic fracture within 3 years. The risk was 9.12%, 10.36%, 11.60%, and 12.29% for patients with MPR C 75%, 50 * ~75%, 25 * ~50%, and ~25%, respectively. Simultaneously, those with higher adherence to AOM utilized fewer medical resources in the national insurance healthcare system. The total medical cost for 3 years was 8120, 9151, 8932,9217 USD for patients with MPR C 75%, 50 * ~ 75%, 25 * ~50%, and ~ 25%, respectively. Conclusion: Overall, under Taiwan’s national health insurance, higher adherence to AOMs was cost-saving. The finding of this research was valuable for policymakers in considering healthcare policy and resource allocation.
    日期: 2023-07-21
    關聯: Aging Clinical and Experimental Research. 2023 Jul 21;35:S242.
    Link to: http://dx.doi.org/10.1007/s40520-023-02442-7
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1594-0667&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001058500202011
    顯示於類別:[王貞予] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI001058500202011.pdf68KbAdobe PDF86檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋